VJHemOnc is committed to improving our service to you

EHA 2020 | Real-world data and MRD in CLL

VJHemOnc is committed to improving our service to you

Peter Hillmen

Peter Hillmen, MBChB, FRCP, FRCPath, PhD, of the University of Leeds, Leeds, UK, evaluates the importance and challenges of real-world data and minimal residual disease (MRD) in chronic lymphocytic leukemia (CLL). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter